Latest News and Press Releases

Bio Usawa, a pioneering biotechnology company dedicated to developing affordable monoclonal antibodies in Africa, appointed Dr. Patrick Lukulay as COO.

Bio Usawa, Inc., a company committed to delivering affordable biotherapies in Africa, named Eric Karikari-Boateng its Head of Global Regulatory Strategy

Bio Usawa and the Rwanda Development Board have partnered to establish Rwanda’s first manufacturing plant for affordable treatments for serious eye disease